Date: Dec 29, 2023

--Protect Pharmaceutical Corp." OTC:" Ali Yildiz Addresses shareholders of the company.. We wanted to update shareholders in regards to the progress on our PCAOB Audit. We are preparing multiple new routes that will include South America, Eurasia, Eastern Europe and of course Turkey. [read more...]

Date: Dec 22, 2023

--Protect Pharmaceutical Corp." OTC:" Ali Yildiz Addresses shareholders of the company.. As we stated last week we are in the final stages of our PCAOB audit and expect its completion very soon. We have now responded to the open items to the auditor. [read more...]

Date: Dec 15, 2023

--Protect Pharmaceutical Corp." OTC:" Protect Pharmaceutical Corp. CEO Ali Yildiz Provides Shareholder Update.. As CEO of PRTT I wanted to update shareholders on current progress within the company. Upon finalizing the audit we will prepare and file a form 10 for the company to resume reporting with the SEC and upon the form 10 becoming effective we plan to change [read more...]

Date: Nov 24, 2023

--Protect Pharmaceutical Corp." OTC: PRTT" is pleased to announce the acquisition of Bosfor Export. With this acquisition, PRTT's management is optimistic about significantly increasing revenues by leveraging Bosfor Export's valuable routes and client base, which extends from South America to Eastern Europe. In line with ongoing PCAOB audit requirements, [read more...]

Date: Sep 26, 2023

--Protect Pharmaceutical Corp." OTC:" Protect Pharmaceutical Corp. CEO Ali Yildiz Provides Shareholder Update.. For the 6 months ending June 30, 2023 we had 62 million dollars in revenue with an operating profit of over 18 million dollars. Our expansion plans for the year have been aggressive and our route expansion has included opening new routes throughout the [read more...]

Date: Jun 15, 2023

--Protect Pharmaceutical Corp." OTC:" Protect Pharmaceutical Corp. announces that the Company has appointed PricewaterhouseCoopers in Turkey as the auditor for the Company.. As an independent auditor PWC will conduct the audit of the Company’ s financial statements in accordance with the standards established by the Public Company Accounting Oversight [read more...]

Date: Apr 28, 2023

--Protect Pharmaceutical Corp.‘ s President Ali Yildiz addresses the Company’ s shareholders with a corporate update on expansion and forward-looking progress.. The Company has entered into new shipment route agreements throughout the Black Sea. Also, the Company added substantially to its existing volume of ground shipments on the European routes and [read more...]

Date: Apr 10, 2023

--Protect Pharmaceutical Corp." OTC:" announces the completion of the recent appointment of Ali Yildiz as President and the finalization of the acquisition of Antarax Capital Danismanlik Limited.. With the filing of the new company financials on the OTC Markets website, this completes the initial introduction of an enhanced Protect Pharmaceutical Corp. to [read more...]

Date: Mar 08, 2023

--Protect Pharmaceutical Corp." OTC:" announces the change of control of the Preferred series A shares and the appointment of a new president, Ali Yildiz. Mr. Yildiz has an impressive track record growing companies on a large scale and is looking forward to bringing his skill to create growth and stability for Protect Pharmaceutical. Mr. Yildiz is currently [read more...]

Date: Dec 12, 2022

--Protect Pharmaceutical Corporation, Inc. informs, that the Share Exchange Agreement №1, signed on June 15, 2022 was not executed due to the insufficiency of legal instruments on the territory of the Republic of Belarus for conducting such transactions, and terminated on December 6, 2022.. As per December 6, 2022 the obligations were not executed, and the [read more...]